218 related articles for article (PubMed ID: 17021402)
1. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
[TBL] [Abstract][Full Text] [Related]
2. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Bigl M; Apelt J; Eschrich K; Schliebs R
J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
[TBL] [Abstract][Full Text] [Related]
3. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
Mehlhorn G; Hollborn M; Schliebs R
Int J Dev Neurosci; 2000; 18(4-5):423-31. PubMed ID: 10817926
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
[TBL] [Abstract][Full Text] [Related]
6. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
[TBL] [Abstract][Full Text] [Related]
8. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H
Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276
[TBL] [Abstract][Full Text] [Related]
9. The expression and activity of K
Boscia F; Pannaccione A; Ciccone R; Casamassa A; Franco C; Piccialli I; de Rosa V; Vinciguerra A; Di Renzo G; Annunziato L
Neurobiol Aging; 2017 Jun; 54():187-198. PubMed ID: 28390823
[TBL] [Abstract][Full Text] [Related]
10. Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.
DaRocha-Souto B; Scotton TC; Coma M; Serrano-Pozo A; Hashimoto T; Serenó L; Rodríguez M; Sánchez B; Hyman BT; Gómez-Isla T
J Neuropathol Exp Neurol; 2011 May; 70(5):360-76. PubMed ID: 21487307
[TBL] [Abstract][Full Text] [Related]
11. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
13. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology.
Rossner S; Apelt J; Schliebs R; Perez-Polo JR; Bigl V
J Neurosci Res; 2001 Jun; 64(5):437-46. PubMed ID: 11391698
[TBL] [Abstract][Full Text] [Related]
14. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
[TBL] [Abstract][Full Text] [Related]
15. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.
Praticò D; Uryu K; Leight S; Trojanoswki JQ; Lee VM
J Neurosci; 2001 Jun; 21(12):4183-7. PubMed ID: 11404403
[TBL] [Abstract][Full Text] [Related]
16. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
Rodrigo J; Fernández-Vizarra P; Castro-Blanco S; Bentura ML; Nieto M; Gómez-Isla T; Martínez-Murillo R; MartInez A; Serrano J; Fernández AP
Neuroscience; 2004; 128(1):73-89. PubMed ID: 15450355
[TBL] [Abstract][Full Text] [Related]
19. HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.
Bowers WJ; Mastrangelo MA; Stanley HA; Casey AE; Milo LJ; Federoff HJ
Neurobiol Aging; 2005 Apr; 26(4):393-407. PubMed ID: 15653168
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
